The Journal of Immunology · 2000 · 187 citations · 17 references
The complement anaphylatoxin C3a, via its receptor C3aR, is known to drive pro‑inflammatory responses, yet recent in vitro data suggest C3aR may also exert anti‑inflammatory effects. The study aimed to clarify whether C3aR contributes to the development of endotoxin shock. Loss of C3aR in mice heightened endotoxin‑induced lethality, amplified IL‑1β production, and revealed that C3aR protects against shock by dampening LPS‑induced cytokine release.
Abstract The complement anaphylatoxin C3a, on binding the C3aR, mediates numerous proinflammatory activities. In addition, recent in vitro studies with C3a have implicated C3aR as a possible anti-inflammatory receptor. Because of its possible dual role in modulating the inflammatory response, it is uncertain whether C3aR contributes to the pathogenesis of endotoxin shock. Here, the targeted-disruption of the C3aR in mice is reported. These mice exhibit an enhanced lethality to endotoxin shock with a pronounced gene dosage effect. In addition, the plasma concentration of IL-1β was significantly elevated in the C3aR−/− mice compared with their littermates following LPS challenge. These findings demonstrate an important protective role for the C3aR in endotoxin shock and indicate that, in addition to its traditionally accepted functions in mediating inflammation, the C3aR also acts in vivo as an anti-inflammatory receptor by attenuating LPS-induced proinflammatory cytokine production.
17